Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-11-14

FDA Approved: NEBIVOLOL — Original Application (Lifestar Pharma LLC)

View source ↗

Summary

FDA approves Nebivolol as a generic drug under an original ANDA from Lifestar Pharma LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nebivolol (Nebivolol)

Snippet

ORIG AP for NEBIVOLOL (NEBIVOLOL)